PT - JOURNAL ARTICLE AU - Miranda Houtman AU - Anna Dzebisashvili AU - Espen Hesselberg AU - Anatoly Dubnovitsky AU - Genadiy Kozhukh AU - Lars Rönnblom AU - Lars Klareskog AU - Vivianne Malmström AU - Leonid Padyukov TI - Expression levels of <em>HLA-DRB</em> and <em>HLA-DQ</em> are associated with MHC Class II haplotypes in healthy individuals and rheumatoid arthritis patients AID - 10.1101/2021.01.06.20249032 DP - 2021 Jan 01 TA - medRxiv PG - 2021.01.06.20249032 4099 - http://medrxiv.org/content/early/2021/01/06/2021.01.06.20249032.short 4100 - http://medrxiv.org/content/early/2021/01/06/2021.01.06.20249032.full AB - HLA-DRB1 alleles have been associated with several autoimmune diseases. In anti-citrullinated protein antibody positive rheumatoid arthritis (ACPA-positive RA), HLA-DRB1 shared epitope (SE) alleles are the major genetic risk factors. In order to investigate whether expression of different alleles of major histocompatibility complex (MHC) Class II genes influence functions of immune cells, we investigated transcriptomic profiles of a variety of immune cells from healthy individuals carrying different HLA-DRB1 alleles. Sequencing libraries from peripheral blood mononuclear cells, CD4+ T cells, CD8+ T cells, and CD14+ monocytes of 32 genetically pre-selected healthy female individuals were generated, sequenced and reads were aligned to the standard reference. For the MHC region, reads were mapped to available MHC reference haplotypes and AltHapAlignR was used to estimate gene expression. Using this method, HLA-DRB and HLA-DQ were found to be differentially expressed in different immune cells of healthy individuals as well as in whole blood samples of RA patients carrying HLA-DRB1 SE-positive versus SE-negative alleles. In contrast, no genes outside the MHC region were differentially expressed between individuals carrying HLA-DRB1 SE-positive and SE-negative alleles. Existing methods for HLA-DR allele-specific protein expression were evaluated but were not mature enough to provide appropriate complementary information at the protein level. Altogether, our findings suggest that immune effects associated with different allelic forms of HLA-DR and HLA-DQ may be associated not only with differences in the structure of these proteins, but also with differences in their expression levels.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the Swedish Research Council [2015-3006, 2018-2399 and 2018-2884], the Swedish Rheumatism Association, King Gustav Vs 80-year Foundation and Borje Dahlin Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This project was undertaken with ethical approval of the regional ethical review board in Uppsala.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll sequencing data generated in this study are available at NCBI Gene Expression Omnibus accession number GSE163605. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE163605